FAKTOR OPTIONSSCHEIN - STRYKER CORP. Stock

Certificat

DE000PL11QE5

Market Closed - Boerse Frankfurt Warrants 15:50:30 2024-06-14 EDT
35.77 EUR -2.05% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
Current month-14.00%
1 month-52.96%
Date Price Change
24-06-14 36.42 -0.27%
24-06-13 36.52 +12.93%
24-06-12 32.34 -4.85%
24-06-11 33.99 +9.36%
24-06-10 31.08 +2.20%

Real-time Boerse Frankfurt Warrants

Last update June 14, 2024 at 03:50 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PL11QE
ISINDE000PL11QE5
Date issued 2024-02-16
Strike 343 $
Maturity Unlimited
Parity 1 : 1
Emission price 50
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 89.4
Lowest since issue 26.67
Spread 1.12
Spread %3.12%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
345 USD
Average target price
372.5 USD
Spread / Average Target
+7.98%
Consensus